Author: admin

How Is the MPA Being Qualified by the FDA?

In 2021, we began working with the FDA to qualify the MPA as a Drug Development Tool through the ISTAND program. While the FDA […]

USPTO Allows Antibody Genus Claims in Patent Enabled by Integral Molecular’s Paratope-PLUS™ CDR-Scanning

Data-Driven Technology Re-establishes a Pathway for Antibody Genus Claims that Meet US Patent Requirements Philadelphia – Integral Molecular, the industry leader in the discovery […]

Are Tissue Cross-Reactivity Studies Sufficient for Biotherapeutic Specificity Testing?

Even though TCR is widely used and has long been recommended by the FDA, it has a long and much-discussed list of limitations. There […]

Integral Molecular Appoints Cheryl Paes as Vice President of Commercial Strategy

Philadelphia – Integral Molecular, the industry leader in the discovery and characterization of antibodies against membrane proteins, announces that Cheryl Paes has joined the […]

What Tools Are Available for Specificity Testing During Drug Development?

Even though monoclonal antibodies are prized for their specificity, 1 in 3 lead candidates exhibit off-target binding. Because off-target interactions are so common and their safety consequences so large, we need accurate methods for identifying them. […]

Follow Our DDT Qualification Journey

Welcome to Specificity Insights, our blog about current developments in antibody specificity testing! Over the coming months, we’ll be releasing a multi-part series about […]

Webinar Presented by Integral Molecular and IPWatchdog – Resurrecting Antibody Genus Protection: Allowed Claims Through CDR-Scanning

Thursday, March 5, 2026 12 pm ET View the recording New antibody patenting strategies, such as structure-based genus and means plus function claims, are […]

Integral Molecular’s Membrane Proteome Array™ Nears FDA Qualification as a Drug Development Tool

MPA on track to become the first NAM approved by the FDA for specificity testing Philadelphia – Integral Molecular, a leader in antibody discovery […]

10x Faster Virus Neutralization Testing With Launch of Integral Molecular’s Ready Reporter Virus™ Kit

Automation-compatible, safe assay delivers same-day results to accelerate vaccine and therapeutic antibody development Philadelphia – Integral Molecular, a leader in developing innovative tools for […]